(Q34309004)

1 August 2017

2 references

16 May 2022

10 January 2024

Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine (English)

1 reference

Colony stimulating factor 2

1 August 2017

1 reference

3 November 2019

1 reference

20 November 2019

1 reference

21 December 2019

7

Harriet L Robinson

1 reference

1 August 2017

Shan Lu

4

0 references

author name string

Michael Hellerstein

1

1 reference

1 August 2017

Yongxian Xu

2

1 reference

1 August 2017

Tracie Marino

3

1 reference

1 August 2017

Hong Yi

5

1 reference

1 August 2017

Elizabeth R Wright

6

1 reference

1 August 2017

publication date

30 October 2012

1 reference

Human Vaccines & Immunotherapeutics

1 August 2017

1 November 2012

6 references

20 June 2019

3 November 2019

20 November 2019

21 December 2019

16 May 2022

10 January 2024

7 references

1 August 2017

20 June 2019

3 November 2019

20 November 2019

21 December 2019

16 May 2022

10 January 2024

8

1 reference

1 August 2017

issue

11

1 reference

1 August 2017

page(s)

1654-1658

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

1 August 2017

copyright license

6 references

20 June 2019

3 November 2019

20 November 2019

21 December 2019

16 May 2022

Viral vectored granulocyte-macrophage colony stimulating factor inhibits vaccine protection in an SIV challenge model: protection correlates with neutralizing antibody

10 January 2024

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601140

SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601140

Prevention of infection by a granulocyte-macrophage colony-stimulating factor co-expressing DNA/modified vaccinia Ankara simian immunodeficiency virus vaccine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601140

Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601140

Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601140

Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601140

High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601140

Strategies for designing and optimizing new generation vaccines

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601140

GM-CSF-based cellular vaccines: a review of the clinical experience

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601140

Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601140

Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601140

Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601140

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3601140

DNA/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FHV.21978

Multiprotein HIV type 1 clade B DNA/MVA vaccine: construction, safety, and immunogenicity in Macaques

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.4161%2FHV.21978

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23111169

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23111169

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/HV.21978

1 reference

1 August 2017

1 reference

1 August 2017

1 reference